Chemotherapy and cognitive impairment: treatment options (Q37911248)

25 August 2017

1 reference

title

Chemotherapy and cognitive impairment: treatment options (English)

1 reference

25 August 2017

1 reference

cognitive dysfunction

1 reference

2

J Vardy

1 reference

25 August 2017

1

J E Fardell

1 reference

25 August 2017

4

G Winocur

1 reference

25 August 2017

I N Johnston

3

1 reference

PubMed ID

21814191

25 August 2017

language of work or name

English

0 references

publication date

3 August 2011

1 reference

Clinical Pharmacology & Therapeutics

25 August 2017

1 reference

25 August 2017

90

1 reference

25 August 2017

3

1 reference

25 August 2017

366-376

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2011.112

25 August 2017

0 references

cites work

Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Cognitive function after chemotherapy in adults with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Cognitive function in breast cancer patients prior to adjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Cytokines and their relationship to the symptoms and outcome of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Candidate mechanisms for chemotherapy-induced cognitive changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Hippocampal brain amines in methotrexate-induced learning and memory deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Erythropoietin and neuroprotection: a therapeutic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Predictors of cognitive decline after chemotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Use of psychostimulants in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Modafinil: a review of neurochemical actions and effects on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

The effect of modafinil on cognitive function in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Therapeutic potential of fluoxetine in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Grape juice, berries, and walnuts affect brain aging and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

High-fat diets, insulin resistance and declining cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Cognitive impairment following high fat diet consumption is associated with brain inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Ginkgo biloba: specificity of neuropsychological improvement--a selective review in search of differential effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Cognitive rehabilitation in the elderly: effects on memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Cognitive-behavioral management of chemotherapy-related cognitive change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Fitness effects on the cognitive function of older adults: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Exercise builds brain health: key roles of growth factor cascades and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Aerobic fitness is associated with hippocampal volume in elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Medium-term effects of chemotherapy in older cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

The effects of chemotherapy on Useful Field of View (UFOV) in younger and older breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

7 January 2021

Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

7 January 2021

Fatigue and cancer: causes, prevalence and treatment approaches

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

7 January 2021

Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

7 January 2021

Donepezil: potential neuroprotective and disease-modifying effects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

7 January 2021

Exercise programs for cancer-related fatigue: evidence and clinical guidelines

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

7 January 2021

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

7 January 2021

Short-term monitoring of cognitive functions before and during the first course of treatment

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.112

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.112

1 reference

PubMed ID

21814191

Dimensions Publication ID

25 August 2017

0 references

1 reference

PubMed ID

21814191